Pharmafile Logo

WG Consulting

The WG Group provides bespoke Market Access consultancy services for all healthcare stakeholders. These include the pharmaceutical, medical devices and diagnostics industries, the independent sector, European state healthcare providers and academia. Its unique blend of experience and expertise enables the WG Group to provide innovative solutions effectively tailored to clients’ needs. The WG Group is part of the Grey Healthcare Group, one of the world’s largest healthcare communications agency networks and part of the WPP Group of companies which gives our clients access to an unparalleled breadth of global expertise.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

WG House, 2 Cressex Road, High Wycombe, Buckinghamshire, HP12 4TY, United Kingdom
+44 (0)1494 470760

 Latest Content from PMHub 

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Petauri Evidence

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...

Product launch: What market research when?

White Papers and Resources | February 14, 2024 | Inizio

Get the insights you need, when you need them, for your product launch planning

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Top-5 Trends in Virtual KOL Engagement

Press Releases | February 12, 2024 | Impetus Digital

Register now for one of our upcoming webinars (February 26-28)

Therapy Watch launches new tracker covering Alzheimer’s Disease

White Papers and Resources | February 12, 2024 | Inizio

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Medscape Education Leads the Industry into New Era of Precision Education with Guaranteed Impact

Press Releases | February 9, 2024 | Medscape Education

NEWARK, N.J., Feb. 8, 2024 /PRNewswire/ -- Medscape Education has just unveiled its pioneering approach to developing and delivering medical education designed to drive guaranteed reach, precision targeting, and impact during this...

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

White Papers and Resources | February 9, 2024 | Inizio

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Hitting Every Beat—The Power of Education in Heart Failure

Press Releases | February 8, 2024 | Medscape Education

Heart failure can be a challenge to manage both for clinicians and patients. It’s a complex condition with various manifestations and presentations, and different disease stages that require different approaches...